Работы, на которые ссылается эта работа

Работ: 171

Работа: Exploring cellular immunotherapy platforms in multiple myeloma

Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
Cheng Sun, Haoyu Sun, Weihua Xiao +2
Обзорная статья2015Цитирований: 2
ABI
Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma
Thanh-Nhan Nguyen-Pham, Sung‐Hoon Jung, Manh-Cuong Vo +7
Статья2015Цитирований: 2
ABI
NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma
Cheng Sun, Haoyu Sun, Cai Zhang +1
Обзорная статья2014Цитирований: 2
ABI
Are natural killer cells superior CAR drivers?
Hans Klingemann
Статья2014Цитирований: 2
ABI
Emerging combination treatment strategies containing novel agents in newly diagnosed multiple myeloma
Sagar Lonial, Jamie Cavenagh
Обзорная статья2009Цитирований: 2
ABI
Personalized Dendritic Cell-Based Tumor Immunotherapy
Nona Janikashvili, Nicolas Larmonier, Emmanuel Katsanis
Обзорная статья2009Цитирований: 2
ABI
Transfection of chimeric anti‐CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells
Hua Jiang, Wenhao Zhang, Peipei Shang +10
Статья2013Цитирований: 2
ABI
Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells
Loek J. Eggermont, Leonie E. Paulis, Jurjen Tel +1
Обзорная статья2014Цитирований: 2
ABI
Enhancement of Dendritic Cells as Vaccines for Cancer
Meghan E. Turnis, Cliona M. Rooney
Обзорная статья2010Цитирований: 2
ABI
Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6
Marina Ratta, Francesco Fagnoni, Antonio Curti +9
Статья2002Цитирований: 2
ABI
Regulation of Dendritic Cell Migration to the Draining Lymph Node
Alfonso Martin‐Fontecha, Silvia Sebastiani, Uta E. Höpken +4
Статья2003Цитирований: 2
ABI
Targeting B-Cell Maturation Antigen in Multiple Myeloma
Yu‐Tzu Tai, Kenneth C. Anderson
Обзорная статья2015Цитирований: 2
ABI
Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma
Kimberly Noonan, Carol Ann Huff, Janice M. Davis +16
Статья2015Цитирований: 2
ABI
The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies
Valentina Hoyos, Ivan Borrello
Обзорная статья2016Цитирований: 2
ABI
T cells in multiple myeloma display features of exhaustion and senescence at the tumor site
Claudia Zelle‐Rieser, Shanmugapriya Thangavadivel, R. Biedermann +5
Статья2016Цитирований: 2
ABI
Global Manufacturing of CAR T Cell Therapy
Bruce L. Levine, James Miskin, Keith Wonnacott +1
Обзорная статья2017Цитирований: 2
ABI
A phase I clinical study of autologous dendritic cell therapy in patients with relapsed or refractory multiple myeloma
Sung‐Hoon Jung, Hyunju Lee, Youn-Kyung Lee +5
Статья2017Цитирований: 2
ABI
Immunotherapy for the treatment of multiple myeloma
Sung‐Hoon Jung, Hyunju Lee, Manh-Cuong Vo +2
Обзорная статья2017Цитирований: 2
ABI
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett +37
Статья2017Цитирований: 2
ABI
Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors
Vincent Yi Sheng Oei, Marta Siernicka, Agnieszka Graczyk‐Jarzynka +14
Статья2018Цитирований: 2
ABI
Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma
Manh-Cuong Vo, Sung‐Hoon Jung, Tan-Huy Chu +6
Статья2018Цитирований: 2
ABI
Synergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma Model
Manh-Cuong Vo, Seoyun Yang, Sung‐Hoon Jung +6
Статья2018Цитирований: 2
ABI
Cellular immunotherapy in multiple myeloma
Manh-Cuong Vo, Thangaraj Jaya Lakshmi, Sung‐Hoon Jung +7
Обзорная статья2019Цитирований: 2
ABI
CAR T-Cell Associated Neurotoxicity: Mechanisms, Clinicopathologic Correlates, and Future Directions
Bradley D. Hunter, Caron A. Jacobson
Статья2019Цитирований: 2
ABI
Role of ADAM17 as a regulatory checkpoint of CD16A in NK cells and as a potential target for cancer immunotherapy
Jianming Wu, Hemant Kumar Mishra, Bruce Walcheck
Обзорная статья2019Цитирований: 2
ABI